DE69327127D1 - Transdermal anzuwendende Arzneizusammensetzungen - Google Patents

Transdermal anzuwendende Arzneizusammensetzungen

Info

Publication number
DE69327127D1
DE69327127D1 DE69327127T DE69327127T DE69327127D1 DE 69327127 D1 DE69327127 D1 DE 69327127D1 DE 69327127 T DE69327127 T DE 69327127T DE 69327127 T DE69327127 T DE 69327127T DE 69327127 D1 DE69327127 D1 DE 69327127D1
Authority
DE
Germany
Prior art keywords
medicinal compositions
used transdermally
transdermally
cor1
loweralkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69327127T
Other languages
English (en)
Other versions
DE69327127T2 (de
Inventor
Kim H Kwon
Barry Koplowitz
Norman L Henderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DE69327127D1 publication Critical patent/DE69327127D1/de
Publication of DE69327127T2 publication Critical patent/DE69327127T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
DE69327127T 1992-03-30 1993-03-26 Transdermal anzuwendende Arzneizusammensetzungen Expired - Fee Related DE69327127T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85974592A 1992-03-30 1992-03-30

Publications (2)

Publication Number Publication Date
DE69327127D1 true DE69327127D1 (de) 2000-01-05
DE69327127T2 DE69327127T2 (de) 2000-05-31

Family

ID=25331608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69327127T Expired - Fee Related DE69327127T2 (de) 1992-03-30 1993-03-26 Transdermal anzuwendende Arzneizusammensetzungen

Country Status (15)

Country Link
US (1) US5482970A (de)
EP (1) EP0563813B1 (de)
JP (1) JPH069389A (de)
KR (1) KR930019218A (de)
AT (1) ATE187065T1 (de)
AU (1) AU658487B2 (de)
CA (1) CA2092861A1 (de)
DE (1) DE69327127T2 (de)
DK (1) DK0563813T3 (de)
ES (1) ES2140422T3 (de)
GR (1) GR3032518T3 (de)
MX (1) MX9301752A (de)
NZ (1) NZ247257A (de)
PT (1) PT563813E (de)
TW (1) TW224048B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
GR1002807B (el) 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
ES2341090T3 (es) * 2000-08-30 2010-06-15 Unimed Pharmaceuticals, Llc Procedimiento para tratar la disfuncion erectil y aumentar la libido en hombres.
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6495158B1 (en) 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
EA012754B1 (ru) 2005-10-12 2009-12-30 Юнимед Фармасьютикалз Ллк Усовершенствованный тестостероновый гель и способ его применения
FR2953833B1 (fr) * 2009-12-10 2012-01-13 Galderma Res & Dev Derives de nouveaux peroxydes, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique pour le traitement ou la prevention de l'acne
FR2953832B1 (fr) 2009-12-10 2012-01-13 Galderma Res & Dev Derives de nouveaux peroxydes, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique pour le traitement ou la prevention de l'acne

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4017641A (en) * 1975-01-31 1977-04-12 The Procter & Gamble Company Skin moisturizing compositions containing 2-pyrrolidinone
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
FR2500441A1 (fr) * 1981-02-23 1982-08-27 Roussel Uclaf Nouveaux medicaments derives de la 3-hydroxy dodecahydro benz (e) inden-7-one, produits derives de la 3-hydroxy dodecahydro benz (e) inden-7-one et leur procede de preparation
US4879119A (en) * 1984-02-21 1989-11-07 Yamanouchi Pharmaceutical Co., Ltd. Patch
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
IL72684A (en) * 1984-08-14 1989-02-28 Israel State Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US4810499A (en) * 1984-10-01 1989-03-07 Biotek, Inc. Transdermal drug delivery system and method
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
US4788062A (en) * 1987-02-26 1988-11-29 Alza Corporation Transdermal administration of progesterone, estradiol esters, and mixtures thereof
US4900555A (en) * 1987-02-26 1990-02-13 Alza Corporation Skin permeation enhancer compositions using sucrose esters
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
US4804541A (en) * 1987-08-11 1989-02-14 Moleculon, Inc. Transdermal administration using benzyl alcohol
US4885154A (en) * 1988-03-01 1989-12-05 Alza Corporation Method for reducing sensitization or irritation in transdermal drug delivery and means therefor

Also Published As

Publication number Publication date
US5482970A (en) 1996-01-09
GR3032518T3 (en) 2000-05-31
MX9301752A (es) 1993-09-01
CA2092861A1 (en) 1993-10-01
ATE187065T1 (de) 1999-12-15
JPH069389A (ja) 1994-01-18
AU3559993A (en) 1993-10-07
DE69327127T2 (de) 2000-05-31
DK0563813T3 (da) 2000-05-22
EP0563813B1 (de) 1999-12-01
AU658487B2 (en) 1995-04-13
EP0563813A1 (de) 1993-10-06
KR930019218A (ko) 1993-10-18
NZ247257A (en) 1995-07-26
TW224048B (de) 1994-05-21
ES2140422T3 (es) 2000-03-01
PT563813E (pt) 2000-04-28

Similar Documents

Publication Publication Date Title
NO941662D0 (no) Benzofuranyl- og -tiofenyl-alkankarboksylsyrederivater
AU1492795A (en) Retroviral protease inhibiting compounds
ES2090366T3 (es) Compuestos hexaciclicos.
DE69327127T2 (de) Transdermal anzuwendende Arzneizusammensetzungen
NO862750D0 (no) Fremgangsmaate for fremstilling av farmakologisk aktive oksindol-derivater.
CY2529B1 (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU8062487A (en) New substituted cephalosporin sulfones as anti-inflammatory and antidegenerative agents
ATE3052T1 (de) Anaerob haertende klebstoffe und dichtungsmassen.
ES2179254T3 (es) 1-poliarilpirazoles plaguicidas.
FI861698A (fi) 2-pyrrolidonderivat.
ES2176277T3 (es) Derivados heterociclicos carboxialquilicos.
ATE138916T1 (de) Aryl und hetaryl annelierte 2,4-diazocine als anti-arryhthmische wirkstoffe
DE69107541D1 (de) Sterinverbindung.
AU554544B2 (en) 4-(substituted alkyl)-n-(1,3-dithiolan-2-ylidene) aniline
AR245941A1 (es) Procedimiento para preparar derivados de 1,4-dihidropiridina
ES8606273A1 (es) Un procedimiento para la preparacion de compuestos de 2- oxindol
LU88449I2 (fr) Fleroxacine et ses dérivés pharmaceutiquement acceptables.
IT1201444B (it) Fosfonopiridine a loro 1,4-diidroderivati

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee